Medicines, Ethics and Practice: a guide for pharmacists

December 2006 amendments

In the first issue of each month The Journal updates the guidance on the legal status of medicines published in the 30th (July 2006) edition of 'Medicines, ethics and practice: A guide for pharmacists'.	The amendments are given in bold type when added to the list and repeated each month in light type. A product's legal status can be obtained by consulting first the latest amendment list and then the guide. The abbreviations used in the list are explained in the key to annotations in the body of the guide (p33).
Human medicines
Abilify tablets entry should read: Abilify preparations POM Acomplia tablets POM Anadin Ultra Double Strength capsules P Baraclude tablets POM Bisodol Extra tablets GSL Champix tablets POM Clairette 2000/35 POM Clenil Modulite inhaler POM Competact tablets POM Detrunorm XL capsules POM DulcoEase capsules GSL Emselex tablets POM Erdotin capsules POM Etopan XL tablets POM Evoltra solution for infusion POM Evotrox oral solution POM Exjade dispersible tablets POM Exubera insulin POM Gardisil suspension for injection POM	Ibuprofen entry: after “in the case of liquid preparations of ibuprofen, individual unit doses of not more than 5ml each to a maximum of 20 unit doses GSL;” add “ibuprofen oral suspension with a strength of 2% or less, supplied in multidose containers of not more than 100ml, GSL;” Infanrix-IPV+Hib POM Loratidine entry: change “and in children aged 12 years and over” to “and in children aged two years and over and weighing 30kg or more” Metoject injections POM Metsol oral solution POM Nexavar tablets POM Nicorette microtab entry should read: Nicorette Microtab GSL Penciclovir entry should read: Penciclovir POM, but as 1% cream for treatment of cold sores in adults and children over 12 years P Preotact POM Prialt solution for infusion POM Sprycel tablets POM Sutent capsules POM Tysabri solution for infusion POM